PLUS1
35.05
-1.32 (-3.63%)
-1.32 (-3.63%)
Upgrade to Real-Time
Regular Market
Low
24.775
High
55.36
Best deals to access real time data! |
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Y mAbs Therapeutics Inc | YMAB | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -1.32 | -3.63% | 35.05 | 14:37:47 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 36.19 | 34.22 | 36.88 | 36.37 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 34.98 | 35.04 | 0.06 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,772 | 116,604 | $ 35.47 | $ 4,135,528 | 271,342 | 24.775 - 55.36 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:39:07 | 1 | $ 35.01 | USD |
Y mAbs Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 1.53B | 43.57M | 34.63M | $ 20.75M | $ - | -2.97 | -23.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | -1.10M | 1.00% |
Y mAbs Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical YMAB Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.07 | 38.39 | 33.99 | 36.55 | 279,850 | -0.02 | -0.06% |
| 1 Month | 33.50 | 38.39 | 32.80 | 35.59 | 239,656 | 1.55 | 4.63% |
| 3 Months | 35.12 | 38.39 | 24.775 | 31.12 | 278,350 | -0.07 | -0.2% |
| 6 Months | 52.37 | 54.8603 | 24.775 | 37.30 | 283,519 | -17.32 | -33.07% |
| 1 Year | 41.16 | 55.36 | 24.775 | 39.58 | 231,485 | -6.11 | -14.84% |
| 3 Years | 26.50 | 55.36 | 14.16 | 33.01 | 194,282 | 8.55 | 32.26% |
| 5 Years | 26.50 | 55.36 | 14.16 | 33.01 | 194,282 | 8.55 | 32.26% |
Y mAbs Therapeutics Description
| Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. Its pipeline covers Naxitamab, Omburtamab, GD2-GD3 Vaccine, and others. |
